Company / EPS (Basic)
Cullinan Therapeutics, Inc. EPS (Basic) History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$3.69
FY2023
5-year range
-$3.69 / $2.46
FY2022-FY2023
Trend
-250.0%
vs FY2022
Sector context
#162 of 208
Health Care
What the data says
Cullinan Therapeutics, Inc.'s eps (basic) of $-3.69 is lower than 78% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
-3.69 in FY2023.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 208This company -$3.69 Sector average -$0.90
▼
-307.8% below sector average
Key checks
Key Insights
- In FY2023, eps (basic) decreased 250.0% year-over-year.
- Ranks #162 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$3.69 | -250.0% |
| FY2022 | $2.46 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026